Clinical Variable | Association with Risk-prone Attitude | Association with Any Revascularization | Association with Survival | |||
---|---|---|---|---|---|---|
Main Variable of Interest | OR | 95% CI | OR | 95% CI | RR | 95% CI |
   Risk-prone (versus Non-Risk-Prone) |  |  | 1.12 | 0.97–1.28 | 0.92 | 0.77–1.10 |
Other Variables in Model | Â | Â | Â | Â | Â | Â |
   Age (10-year increments) | 0.98 | 0.98–0.99 | 0.99 | 0.98–0.99 | 1.06 | 1.05–1.07 |
   Female Sex | 0.68 | 0.60–0.77 | 0.90 | 0.76–1.07 | 0.82 | 0.67–1.01 |
   Congestive Heart Failure | 1.02 | 0.84–1.23 | 0.81 | 0.64–1.04 | 1.44 | 1.15–1.80 |
   Peripheral Vascular Disease | 1.09 | 0.89–1.32 | 0.77 | 0.60–0.98 | 1.44 | 1.13–1.84 |
   Chronic Pulmonary Disease | 0.91 | 0.76–1.08 | 0.80 | 0.64–1.00 | 1.16 | 0.92–1.50 |
   Cerebrovascular Disease | 0.97 | 0.78–1.21 | 0.90 | 0.69–1.18 | 1.46 | 1.13–1.90 |
   Elevated Creatinine | 1.30 | 0.80–2.12 | 1.41 | 0.76–2.62 | 1.60 | 1.02–2.52 |
   Renal Dialysis | 1.01 | 0.54–1.88 | 0.33 | 0.17–0.66 | 2.17 | 1.19–3.97 |
   Diabetes Mellitus | 1.04 | 0.90–1.19 | 0.88 | 0.74–1.05 | 1.51 | 1.24–1.83 |
   Hypertension | 0.94 | 0.85–1.05 | 0.94 | 0.82–1.08 | 0.99 | 0.84–1.19 |
   Hyperlipidemia | 1.04 | 0.94–1.16 | 1.25 | 1.08–1.44 | 0.73 | 0.61–0.87 |
   Liver/GI* | 1.04 | 0.80–1.36 | 1.25 | 0.87–1.81 | 1.14 | 0.80–1.62 |
   Malignancy | 1.05 | 0.81–1.37 | 0.95 | 0.68–1.32 | 1.97 | 1.47–2.64 |
   Prior MI* | 1.02 | 0.89–1.16 | 0.68 | 0.57–0.80 | 1.34 | 1.09–1.64 |
   Prior PCI* | 1.01 | 0.83–1.22 | 1.18 | 0.93–1.50 | 0.94 | 0.70–1.26 |
   Prior CABG* Surgery | 0.88 | 0.71–1.07 | 0.26 | 0.21–0.33 | 1.04 | 0.79–1.36 |
   Prior Lytic Therapy | 1.14 | 0.88–1.47 | 1.14 | 0.80–1.62 | 1.06 | 0.72–1.57 |
   Former Smoker | 0.99 | 0.89–1.10 |  |  | 1.28 | 1.07–1.52 |
   Current Smoker | 1.15 | 1.01–1.31 | 1.07 | 0.93–1.23 | 1.48 | 1.19–1.84 |
Clinical Indication | Â | Â | Â | Â | Â | Â |
   Stable Angina (reference) | 1.00 |  | 1.00 |  | 1.00 |  |
   Myocardial Infarction | 0.91 | 0.78–1.07 | 2.74 | 2.24–3.35 | 0.92 | 0.72–1.18 |
   Unstable Angina | 0.88 | 0.77–0.99 | 2.01 | 1.70–2.39 | 0.92 | 0.73–1.16 |
   Other | 0.99 | 0.80–1.22 | 0.96 | 0.72–1.28 | 1.33 | 0.99–1.77 |
Duke Category | Â | Â | Â | Â | Â | Â |
   1-vessel disease (reference) | 1.00 |  | 1.00 |  | 1.00 |  |
   2-vessel disease | 1.10 | 0.94–1.28 | 96.72 | 68.41–136.73 | 0.18 | 0.87–1.60 |
   3-vessel disease | 1.26 | 1.07–1.49 | 161.60 | 112.62–231.88 | 1.54 | 1.14–2.10 |
   left main | 1.22 | 0.98–1.53 | 296.26 | 193.95–452.55 | 1.43 | 0.96–2.12 |
   missing | 0.61 | 0.32–1.17 | 20.49 | 10.09–41.60 | 2.07 | 0.92–4.67 |
Ejection Fraction | Â | Â | Â | Â | Â | Â |
   > 50% (reference) | 1.00 |  | 1.00 |  | 1.00 |  |
   35–50% | 0.91 | 0.80–1.04 | 1.10 | 0.93–1.31 | 1.49 | 1.20–1.84 |
   20–34% | 1.01 | 0.77–1.32 | 0.57 | 0.42–.078 | 3.13 | 2.35–4.16 |
   < 20% | 1.26 | 0.64–2.43 | 0.35 | 0.16–0.77 | 3.83 | 2.10–6.99 |
   not done do to instability | 0.75 | 0.56–0.99 | 1.04 | 0.72–1.50 | 2.09 | 1.55–3.01 |
   missing | 0.84 | 0.59–1.18 | 1.72 | 1.08–2.77 | 1.64 | 0.98–2.59 |
Household Income | Â | Â | Â | Â | Â | Â |
   < $20,000 (reference) | 1.00 |  | 1.00 |  | 1.00 |  |
   $20,000–34,999 | 1.07 | 0.90–1.26 | 0.99 | 0.80–1.22 | 0.79 | 0.63–1.01 |
   $35,000–49,999 | 1.32 | 1.09–1.59 | 1.03 | 0.81–1.31 | 0.82 | 0.62–1.09 |
   $50,000–69,999 | 1.25 | 1.02–1.52 | 1.17 | 0.90–1.52 | 0.53 | 0.67–0.78 |
   ≥ $70,000 | 1.94 | 1.59–2.34 | 1.21 | 0.94–1.58 | 0.73 | 0.51–1.04 |
   Missing | 0.97 | 0.81–1.16 | 1.12 | 0.89–0.42 | 0.74 | 0.57–0.95 |
Treatment Received | Â | Â | Â | Â | Â | Â |
   Medical Therapy (reference) |  |  |  |  | 1.00 |  |
   CABG Surgery |  |  |  |  | 0.53 | 0.41–0.68 |
   PCI |  |  |  |  | 0.64 | 0.51–0.80 |